Anus neoplasm

Related records

Broader conditions (16)

• Anus disorder
• Cancer or benign tumor
• Colorectal neoplasm
• Digestive system disorder
• Digestive system neoplasm
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Human disease
• Intestinal disorder
• Intestinal neoplasm
• Large intestine disorder
• Neoplasm
• Neoplastic disease or syndrome
• Rectal disorder
• Rectal neoplasm

Narrower conditions (29)

• Anal canal adenocarcinoma
• Anal canal carcinoma
• Anal canal carcinoma in situ
• Anal canal neuroendocrine neoplasm
• Anal canal Paget disease
• Anal canal squamous cell carcinoma
• Anal carcinoma
• Anal gland adenocarcinoma
• Anal gland neoplasm
• Anal margin basal cell carcinoma
• Anal margin carcinoma
• Anal margin squamous cell carcinoma
• Anal melanoma
• Anal mucinous adenocarcinoma
• Anal Paget disease
• Anal squamous cell carcinoma
• Anal verrucous carcinoma
• Anus adenocarcinoma
• Anus basaloid carcinoma
• Anus cancer

Trials (292)

• [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
• 4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
• A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
• A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection
• A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
• A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation
• A Phase 1 Study in Participants With Advanced Cancer
• A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
• A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer
• A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal
• A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
• A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
• A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
• A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
• A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
• A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
• A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
• A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand
• A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Drugs in development (8)

• Bizalimogene ralaplasmid Phase 2
• Cetuximab Phase 2
• Cidofovir Phase 3
• Fluorouracil Phase 3
• Indigo Phase 2
• Lopinavir Phase 1
• Mitomycin Phase 3
• Ritonavir Phase 1